Cargando…

Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis

Chemoresistance is a daunting obstacle to the effective treatment of breast cancer patients receiving chemotherapy. Although the mechanism of chemotherapy drug resistance has been explored broadly, the precise mechanism at the proteome level remains unclear. Especially, comparative studies between w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cha, Hyo Kyeong, Cheon, Seongmin, Kim, Hyeyoon, Lee, Kyung-Min, Ryu, Han Suk, Han, Dohyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954867/ https://www.ncbi.nlm.nih.gov/pubmed/35335125 http://dx.doi.org/10.3390/molecules27061762

Ejemplares similares

Mass Spectrometry-Based Proteomic Discovery of Prognostic Biomarkers in Adrenal Cortical Carcinoma
por: Jang, Han Na, et al.
Publicado: (2021)

The proteomic landscape shows oncologic relevance in cystitis glandularis
por: Kim, Jun Yong, et al.
Publicado: (2023)

In-depth proteome analysis of brain tissue from Ewsr1 knockout mouse by multiplexed isobaric tandem mass tag labeling
por: Jung, Jin Woo, et al.
Publicado: (2023)

Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth
por: Jung, Minsun, et al.
Publicado: (2022)

Identification of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer
por: Shin, Dongyoon, et al.
Publicado: (2020)

In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas
por: Kim, Jung Hee, et al.
Publicado: (2021)

Bioinformatics and Drug Discovery
por: Xia, Xuhua
Publicado: (2017)

Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy
por: Thippakorn, Chadinee, et al.
Publicado: (2018)

Bioinformatics in translational drug discovery
por: Wooller, Sarah K., et al.
Publicado: (2017)

Proteomic identification of early urinary-biomarkers of acute kidney injury in preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2020)

Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
por: Kim, Ji Young, et al.
Publicado: (2017)

In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients
por: Park, Joonho, et al.
Publicado: (2020)

Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022)

Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer
por: Lee, Kyung-Min, et al.
Publicado: (2020)

Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
por: Lucarelli, Nicholas, et al.
Publicado: (2023)

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics
por: Gámez-Pozo, Angelo, et al.
Publicado: (2017)

Strategies for translating proteomics discoveries into drug discovery for dementia
por: Halder, Aditi, et al.
Publicado: (2023)

Integration of Proteomics, Bioinformatics, and Systems Biology in Traumatic Brain Injury Biomarker Discovery
por: Guingab-Cagmat, J.D., et al.
Publicado: (2013)

OR32-05 Proteogenomics-based Development For Thyroid Cancer Molecular Classifier
por: Kim, Yoo Hyung, et al.
Publicado: (2023)

Bioinformatics techniques for drug discovery: applications for complex diseases
por: Kaushik, Aman Chandra, et al.
Publicado: (2018)

Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease
por: Park, Jihye, et al.
Publicado: (2021)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
por: Waman, Vaishali P., et al.
Publicado: (2019)

Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
por: Tutone, Marco, et al.
Publicado: (2021)

One-Week Dynamic Changes in Cardiac Proteomes After Cardiac Radioablation in Experimental Rat Model
por: Kim, Byoung Hyuck, et al.
Publicado: (2022)

Quantifiable peptide library bridges the gap for proteomics based biomarker discovery and validation on breast cancer
por: Kim, Sung-Soo, et al.
Publicado: (2023)

Searching for essential genes and drug discovery in breast cancer and periodontitis via text mining and bioinformatics analysis
por: Luo, Lan, et al.
Publicado: (2021)

Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer
por: Alam, Md Shahin, et al.
Publicado: (2022)

Proteomics and genomics: perspectives on drug and target discovery
por: Ahn, Natalie G, et al.
Publicado: (2008)

Identification of Immune-Related Breast Cancer Chemotherapy Resistance Genes via Bioinformatics Approaches
por: Du, Yabing, et al.
Publicado: (2022)

Genomics, Proteomics and Bioinformatics
por: Milosevic, Ira, et al.
Publicado: (2008)

Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2023)

Bioinformatics drives discovery in Biomedicine
por: Gujar, Ravindra, et al.
Publicado: (2020)

Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm
por: Lee, Hyebin, et al.
Publicado: (2022)

Moesin (MSN) as a Novel Proteome-Based Diagnostic Marker for Early Detection of Invasive Bladder Urothelial Carcinoma in Liquid-Based Cytology
por: Park, Jeong Hwan, et al.
Publicado: (2020)

The application of high-throughput proteomics in cytopathology
por: Nikas, Ilias P., et al.
Publicado: (2022)

Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Lee, Hyunju, et al.
Publicado: (2021)

Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
por: Kim, Da Bin, et al.
Publicado: (2022)

Discovering genomics, proteomics, and bioinformatics
por: Campbell, A. Malcolm
Publicado: (2007)

Bioinformatic analysis of proteomics data
por: Schmidt, Andreas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7r8rg1k97rbik7maupb6s1ch7s